Jenburkt Pharmaceuticals share news, announcements and annual reports
NSE: JENBURPHBSE: 524731Pharmaceuticals & BiotechnologySmall Cap
Jenburkt Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1995
Last close ₹866.15up ₹12.55 (1.47%)BSE ₹860.00
Share price at the NSE close on 2 Nov 2026. Previous close ₹853.60.
2 Nov: open ₹863.10, high ₹866.90, low ₹863.00
52-week range of BSE trades to 2 Nov 2026
₹848.05Low, 2 Nov 2026₹1,317.00High, 10 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹382 Cr1,871st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.64
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.39
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.94
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.39%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 53698.1% delivered
Jenburkt Pharmaceuticals share news and announcements
653 announcements, routine notices left out, newest first. Page 12 of 14.
Aug 2013
17 Aug · Updates
With reference to the earlier announcement dated January 29, 2013 about filing of a writ petition against Union of India and National Pharmaceutical Pricing Authority (NPPA), Jenburkt Pharmaceuticals ....
Jul 2013
16 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 16, 2013, has approved the following: 1. Shri. Ashish U. Bhuta ....16 Jul · Limited Review for June 30, 2013
16 Jul · Results
1 Jul · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2013 to September 24, 2013 (both days ....
Jun 2013
14 Jun · Demise of Chairman and Managing Director
Passing away of Shri Uttam N. Bhuta, the beloved and respected Chairman and Managing Director of the Company. He was called ....3 Jun · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 26, 2013 to July 31, 2013 (both days inclusive) ....
May 2013
30 May · Meeting
Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has been recommended a Dividend of Rs. 4.20 (42%) ....30 May · Results
21 May · Board meeting
Meeting of Board of Directors of the Company will be held on May 30, 2013, inter alia, to consider: 1. To take on record the ....
Mar 2013
Feb 2013
8 Feb · Board Meeting on Feb 14, 2013
Meeting of the Board of Directors of the Company will be held on February 14, 2013, inter alia, to consider the following items: ....
Jan 2013
Oct 2012
Aug 2012
Jul 2012
May 2012
28 May · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 25, 2012 to July 31, 2012 for the purpose of ....26 May · Dividend
Board of Directors of the Company at its meeting held on May 26, 2012, inter alia, has recommended a dividend of Rs. 3.50 (35%) per ....26 May · Results
18 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 26, 2012, inter alia: 1. To consider and take on record ....
Jan 2012
27 Jan · Limited Review for Dec 31, 2011
27 Jan · Results
Nov 2011
Oct 2011
22 Oct · Results
Aug 2011
2 Aug · Meeting
The 26th Annual General Meeting (AGM) of the Company held on July 29, 2011, have passed all the Resolutions unanimously as per the Notice ....
Jul 2011
29 Jul · Results
20 Jul · Rating
Company has been awarded an NSIC-CRISIL rating of "NSIC-CRISIL SE-1A" on June 30, 2011. The rating indicates "Highest performance ....19 Jul · Business
Company was bestowed with "National Award for Excellence in Cost Management-2010" as the "FIRST" awardee under the category of the ....
Jun 2011
28 Jun · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 23, 2011 to July 29, 2011 (both days inclusive) ....27 Jun · Results
27 Jun · Dividend
Board of Directors of the Company at its meeting held on June 25, 2011, inter alia, has recommended a Dividend of Rs. 3.50 (35%) per ....17 Jun · Board meeting
Meeting of the Board of Directors of the Company will be held on June 25, 2011, inter alia, to consider the following: 1. To ....
May 2011